Clinical and laboratory experience with a modified low dosage sequential oral contraceptive.
D001835:Body Weight / Q000187:drug effects; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D003464:Culdoscopy; D004717:Endometrium / Q000187:drug effects; D004967:Estrogens / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine; D006801:Humans; D007986:Luteinizing Hormone / Q000652:urine; D009640:Norethindrone / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D010053:Ovary / Q000187:drug effects; D011276:Pregnanediol / Q000652:urine; D011372:Progestins / Q000494:pharmacology; D011863:Radioimmunoassay
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol; D009640:Norethindrone